XTLB
XTL BIOPHARMACEUTICALS LTD
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 20-F | 6/30/2026 | View on SEC |
| 6-K | 6/30/2026 | View on SEC |
| 6-K | 6/29/2026 | View on SEC |
| 6-K | 6/23/2026 | View on SEC |
| 6-K | 5/22/2026 | View on SEC |
| 6-K | 5/15/2026 | View on SEC |
| 6-K | 5/7/2026 | View on SEC |
| NT 20-F | 4/30/2026 | View on SEC |
| 6-K | 4/29/2026 | View on SEC |
| 3 | 3/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XTLB |
| Company Name | XTL BIOPHARMACEUTICALS LTD |
| CIK | 1023549 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| State of Incorporation | L3 |
| Phone | 972 9 955 7080 |